2 results
Not approvedWill not start
The objective is to investigate the accuracy, feasibility and safety of FFR in patients presenting with STEMI and MVD.
Approved WMOCompleted
The primary objectives are to determine the maximum tolerated dose (MTD) and/or recommended phase two dose (RP2D) of ABBV-621 and to evaluate pharmacokinetics (PK) of (A) single agent ABBV-621; and (B) the combination of ABBV-621 and venetoclax in…